NO20030523L - Polymorfer av zaleplon og fremgangsmater for fremstillingen derav - Google Patents

Polymorfer av zaleplon og fremgangsmater for fremstillingen derav

Info

Publication number: NO20030523L
Authority: NO; Norway
Prior art keywords: zaleplon; polymorphs; processes; preparation
Prior art date: 2000-08-03

Application number

NO20030523A

Other languages

English (en)

Other versions

NO20030523D0 (no

Inventor

Farhan Aslam

Brett Cowans

Stephen Robert Byrn

G Patrick Stahly

Original Assignee

Meda Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-03

Filing date

2003-02-03

Publication date

2003-03-11

2003-02-03 Application filed by Meda Ab filed Critical Meda Ab

2003-02-03 Publication of NO20030523D0 publication Critical patent/NO20030523D0/no

2003-03-11 Publication of NO20030523L publication Critical patent/NO20030523L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

NO20030523A 2000-08-03 2003-02-03 Polymorfer av zaleplon og fremgangsmater for fremstillingen derav NO20030523L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22278500P	2000-08-03	2000-08-03
PCT/US2001/024510 WO2002012244A2 (en)	2000-08-03	2001-08-02	Polymorphs of zaleplon and methods for the preparation thereof

Publications (2)

Publication Number	Publication Date
NO20030523D0 NO20030523D0 (no)	2003-02-03
NO20030523L true NO20030523L (no)	2003-03-11

Family

ID=22833666

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030523A NO20030523L (no)	2000-08-03	2003-02-03	Polymorfer av zaleplon og fremgangsmater for fremstillingen derav

Country Status (18)

Country	Link
US (2)	US20020072527A1 (no)
EP (1)	EP1305315A2 (no)
JP (1)	JP2004505979A (no)
KR (2)	KR20030036659A (no)
CN (2)	CN1610682A (no)
AR (1)	AR036324A1 (no)
AU (2)	AU8311901A (no)
BR (1)	BR0113244A (no)
CA (1)	CA2417875C (no)
HU (1)	HUP0303055A3 (no)
IL (1)	IL154088A0 (no)
MX (1)	MXPA03001048A (no)
NO (1)	NO20030523L (no)
NZ (1)	NZ527455A (no)
PL (1)	PL365678A1 (no)
SG (1)	SG125971A1 (no)
WO (1)	WO2002012244A2 (no)
ZA (1)	ZA200300779B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1406871A4 (en) *	2001-06-12	2005-01-26	Biogal Gyogyszergyar	PROCESS FOR THE PRODUCTION OF N- 3- (3-CYANOPYRAZOLO 1,5-A] PYRIMIDINE-7-YLE) PHENYL] -N-ETHYLACETAMIDE (ZALEPLON)
US20050032818A1 (en) *	2001-06-12	2005-02-10	Entire Interest	N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
WO2003011228A2 (en) *	2001-08-01	2003-02-13	Biogal Gyogyszergyar Rt	Purification and crystalline forms of zaleplon
WO2003068238A1 (en) *	2002-02-15	2003-08-21	Biogal Gyogyszergyar Rt.	Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
AU2002343201A1 (en) *	2002-10-16	2004-05-04	Sanmar Speciality Chemicals Limited	Synthesis of zaleplon
US7772394B2 (en)	2003-09-04	2010-08-10	Cipla Limited	Zaleplon synthesis
US20070098788A1 (en) *	2005-10-28	2007-05-03	Gore Subhash P	Non-benzodiazepine hypnotic compositions
EP1956021A1 (en) *	2006-10-11	2008-08-13	Ferrer Internacional, S.A.	Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
US20100196286A1 (en) *	2008-12-01	2010-08-05	Armer Thomas A	Inhalation delivery methods and devices
US8555875B2 (en)	2008-12-23	2013-10-15	Map Pharmaceuticals, Inc.	Inhalation devices and related methods for administration of sedative hypnotic compounds
CN102816163A (zh) *	2012-08-20	2012-12-12	四川禾邦阳光制药股份有限公司	扎来普隆的新晶型及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4626538A (en) *	1983-06-23	1986-12-02	American Cyanamid Company	[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
KR0167261B1 (ko) *	1995-10-19	1999-04-15	문정환	전원공급 제어회로
US5714607A (en) *	1995-12-01	1998-02-03	American Cyanamid Company	Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
AR029780A1 (es) *	2000-12-13	2003-07-16	Gador Sa	Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
WO2003011228A2 (en) *	2001-08-01	2003-02-13	Biogal Gyogyszergyar Rt	Purification and crystalline forms of zaleplon

2001
- 2001-08-02 CN CNA018148565A patent/CN1610682A/zh active Pending
- 2001-08-02 PL PL01365678A patent/PL365678A1/xx not_active Application Discontinuation
- 2001-08-02 KR KR10-2003-7001399A patent/KR20030036659A/ko not_active Ceased
- 2001-08-02 WO PCT/US2001/024510 patent/WO2002012244A2/en not_active Ceased
- 2001-08-02 EP EP01961891A patent/EP1305315A2/en not_active Withdrawn
- 2001-08-02 JP JP2002518219A patent/JP2004505979A/ja active Pending
- 2001-08-02 AU AU8311901A patent/AU8311901A/xx active Pending
- 2001-08-02 IL IL15408801A patent/IL154088A0/xx unknown
- 2001-08-02 CA CA002417875A patent/CA2417875C/en not_active Expired - Fee Related
- 2001-08-02 CN CNA2006100802084A patent/CN1847244A/zh active Pending
- 2001-08-02 AU AU2001283119A patent/AU2001283119B2/en not_active Ceased
- 2001-08-02 NZ NZ527455A patent/NZ527455A/en unknown
- 2001-08-02 MX MXPA03001048A patent/MXPA03001048A/es not_active Application Discontinuation
- 2001-08-02 KR KR1020077015099A patent/KR20070086867A/ko not_active Ceased
- 2001-08-02 US US09/921,017 patent/US20020072527A1/en not_active Abandoned
- 2001-08-02 BR BR0113244-0A patent/BR0113244A/pt not_active IP Right Cessation
- 2001-08-02 HU HU0303055A patent/HUP0303055A3/hu unknown
- 2001-08-02 SG SG200500627A patent/SG125971A1/en unknown
- 2001-08-03 AR ARP010103740A patent/AR036324A1/es unknown
2003
- 2003-01-29 ZA ZA200300779A patent/ZA200300779B/en unknown
- 2003-02-03 NO NO20030523A patent/NO20030523L/no not_active Application Discontinuation
2004
- 2004-08-23 US US10/924,436 patent/US20050176735A1/en not_active Abandoned

Also Published As

Publication number	Publication date
IL154088A0 (en)	2003-07-31
CN1610682A (zh)	2005-04-27
KR20030036659A (ko)	2003-05-09
US20050176735A1 (en)	2005-08-11
KR20070086867A (ko)	2007-08-27
AR036324A1 (es)	2004-09-01
HUP0303055A3 (en)	2004-11-29
MXPA03001048A (es)	2004-02-26
AU8311901A (en)	2002-02-18
CA2417875A1 (en)	2002-02-14
ZA200300779B (en)	2003-08-22
CN1847244A (zh)	2006-10-18
JP2004505979A (ja)	2004-02-26
AU2001283119B2 (en)	2007-11-15
NZ527455A (en)	2005-07-29
NO20030523D0 (no)	2003-02-03
BR0113244A (pt)	2003-07-08
CA2417875C (en)	2008-12-09
EP1305315A2 (en)	2003-05-02
PL365678A1 (en)	2005-01-10
HUP0303055A2 (hu)	2004-01-28
WO2002012244A3 (en)	2002-06-13
US20020072527A1 (en)	2002-06-13
WO2002012244A2 (en)	2002-02-14
SG125971A1 (en)	2006-10-30

Similar Documents

Publication	Publication Date	Title
NO20054715L (no)	2000-10-02	Fremgangsmater og mellomprodukter for fremstilling av anti-cancer forbindelser
NO20030844D0 (no)	2003-02-24	Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
NO20044533D0 (no)	2004-10-21	Fremgangsmate for fremstilling av 7-substituerte 3-kinolin og 3-kinol-4-onkarbonitriler
NO20030707D0 (no)	2003-02-14	Polymorfer av en epothilon-analog
CY2013011I2 (el)	2015-08-05	Μεθοδος χορηγησης διφωσφονικων
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20032332D0 (no)	2003-05-22	Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav
NO20021412L (no)	2002-04-17	Soyamelkeblandinger og fremgangsmåter for fremstilling
NO20022176D0 (no)	2002-05-07	Absorberende gjenstand og fremgangsmåte for fremstilling av denne
NO20015542L (no)	2002-01-14	Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DK1328538T3 (da)	2008-11-03	Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener
NO20011026D0 (no)	2001-02-28	Matvare og fremgangsmÕte for fremstilling derav
NO20020622D0 (no)	2002-02-08	Polymorfer av torsemid
NO20030523L (no)	2003-03-11	Polymorfer av zaleplon og fremgangsmater for fremstillingen derav
NO20003555L (no)	2002-01-11	Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
NO20021124D0 (no)	2002-03-06	Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor
NO20035538D0 (no)	2003-12-11	Fremgangsmåte for fremstilling av zaleplon
NO20040887L (no)	2004-02-27	Rensing og krystallinske former av zaleplon.
NO20030515L (no)	2003-03-31	Fremgangsmåte for fremstilling av dinapsolin
NO20024413D0 (no)	2002-09-16	Fremgangsmåte for tilvirkning og bruk av mikrogrupper av biologiske materialer
NO20033743L (no)	2003-10-16	Fremgangsmåte og fremstilling citalopram
EE200200410A (et)	2003-12-15	Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid
NO20023702L (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20035668D0 (no)	2003-12-18	Antitumorformuleringer av tioxantenon
EE200200053A (et)	2003-04-15	Isoretinoiini valmistamise protsess

Legal Events

Date	Code	Title	Description
2010-07-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application